Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rite Aid Rebate Accounting Is One Issue In Philadelphia PBM Investigation

Executive Summary

The Philadelphia U.S. Attorney's Office is investigating whether AdvancePCS properly reported all rebates to Federal Employee Health Benefit Programs during the period of its ownership by Rite Aid

You may also be interested in...



Rx Reimportation Could Help PBMs Reduce Costs, Caremark SEC Filing Says

Caremark expects pharmacy benefit managers to benefit from prescription drug reimportation, the company's Securities & Exchange Commission filing regarding its proposed merger with AdvancePCS states

Rx Reimportation Could Help PBMs Reduce Costs, Caremark SEC Filing Says

Caremark expects pharmacy benefit managers to benefit from prescription drug reimportation, the company's Securities & Exchange Commission filing regarding its proposed merger with AdvancePCS states

FTC Review Of Caremark Deal Will Be Fourth Look At PCS

FTC's review of the Caremark/AdvancePCS merger will be the agency's fourth look at the PCS pharmacy benefit management business in less than a decade - but the first time the agency has considered a straightforward horizontal merger among independent, stand-alone PBMs

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS040277

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel